Several chronic neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), and Parkinson’s disease (PD), are also linked to increased activation of RIPK1 [122,123,124]. This evidence concerns the gene RIPK1 and Parkinson disease.